The observed focal amplifications of the ERBB2 genomic region and the increase in gene expression levels of the genes herein suggest that a proportion of CHEK2*1100delC breast cancers could be related to the ERBB2/Her2Neu intrinsic subtype. The gene discussed is CHEK2; the disease is breast cancer.